Some patients may respond better to one medication than the other based on the drug's reasons for use ... and effectiveness of using both eye drops together. Xiidra and Restasis can be used ...

Novartis paid Takeda $3.4 billion for its FDA-approved dry eye drug Xiidra during the Japanese ... has just announced FDA approval of a phase 3 trial for eye drops containing tivanisiran, in ...

Novartis’ decision to withdraw a European filing for its dry-eye drug Xiidra is to have a knock-on effect on Takeda, causing it to make a loss of $200 million this quarter. Already approved ...